Adherence logger for a dry powder inhaler: A new device for medical adherence research - 25/08/11
, Andrea J. Apter, MD, MSc b, c
Reprint requests: Daniel Bogen, MD, PhD, Department of Bioengineering, University of Pennsylvania, 120 Hayden Hall, 3320 Smith Walk, Philadelphia, PA 19104.Philadelphia, Pa
Résumé |
Background |
Adherence to inhaled steroid regimens is frequently poor. Finding ways to improve adherence depends on the ability to measure time and date of inhaler use reliably and to detect deliberate dose dumping. There is no such monitor for the popular new dry powder inhalers.
Objective |
To develop and test an electronic monitor for a dry powder inhaler that will provide information on the time and date of use.
Methods |
An electronic adherence monitor for the Advair Diskus dry powder inhaler was developed and tested. In this device, inhaler use is determined by detecting and recording the motion of the drug delivery lever in the inhaler with a magnetic sensor. An additional electronic interface and software were also developed to allow the adherence data to be uploaded to a computer for display and analysis.
Results |
System and reliability tests involving multiple-day and repeated-use tests of the adherence monitor demonstrate the overall performance and reliability of the device, and specifically its ability to record the time and date of dose delivery. In the repeated-use test, 300 successive actuations of the dose delivery lever were correctly sensed and recorded without error.
Conclusion |
The simple-to-use, low-cost, reusable adherence monitor accurately records time and date of inhaler use and thus allows clinical monitoring and adherence studies in patients using the Advair Diskus dry powder inhaler. The same technology should be adaptable to other dry powder inhalers, including the Pulmicort Tubuhaler and the Symbicort Tubuhaler.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, adherence, inhaled corticosteroids, clinical research
Abbreviations used : DAL, DPI, ICS
Plan
| Supported by the University Research Foundation and the National Heart, Lung and Blood Institute (HL04337-01; Dr Apter). Disclosure of potential conflict of interest: The authors have no financial relationship with any company concerning the work described in this manuscript, nor any other conflict of interest. |
Vol 114 - N° 4
P. 863-868 - octobre 2004 Retour au numéro
Article précédent
- Clinical effectiveness of a mite allergen–impermeable bed-covering system in asthmatic mite-sensitive patients
- Lisette van den Bemt, Lieke van Knapen, Marjolein P. de Vries, Margreet Jansen, Sonja Cloosterman, Constant P. van Schayck
- Stinging insect hypersensitivity: A practice parameter update
- John E. Moffitt, David B.K. Golden, Robert E. Reisman, Rufus Lee, Richard Nicklas, Theodore Freeman, Richard deShazo, James Tracy, I. Leonard Bernstein, Joann Blessing-Moore, David A. Khan, David M. Lang, Jay M. Portnoy, Diane E. Schuller, Sheldon L. Spector, Steven A. Tilles
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?